Aelix Therapeutics Overview

  • Year Founded
  • 2015

Year Founded

  • Status
  • Out of Business

  • Employees
  • 5

Employees

  • Latest Deal Type
  • Out of Business

Aelix Therapeutics General Information

Description

Operator of a therapeutic vaccine biotechnology company intended to cure HIV infection. The company's vaccine is based on an observation of a T-cell immunogen that can elicit a strong broad and focused response against HIV and has the potential to radically transform the treatment of HIV infection, enabling patients to get cured of rare diseases.

Contact Information

Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Parc Científic de Barcelona
  • Carrer Baldiri Reixac 4-8
  • 08028 Barcelona
  • Spain
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Therapeutic Devices
Vertical(s)
Corporate Office
  • Parc Científic de Barcelona
  • Carrer Baldiri Reixac 4-8
  • 08028 Barcelona
  • Spain

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Aelix Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Out of Business 07-Nov-2025 Completed Out of Business
5. Early Stage VC 12-Jun-2018 Completed Generating Revenue
4. Early Stage VC 23-Nov-2017 Completed Generating Revenue
3. Grant 01-Jan-2017 Completed Generating Revenue
2. Accelerator/Incubator 01-Jan-2017 $52.6K $4.42M Completed Generating Revenue
1. Early Stage VC (Series A) 11-Jan-2016 $4.36M $4.36M Completed Generating Revenue
To view Aelix Therapeutics’s complete valuation and funding history, request access »

Aelix Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Ordinary Shares
Ordinary Shares
To view Aelix Therapeutics’s complete cap table history, request access »

Aelix Therapeutics Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a therapeutic vaccine biotechnology company intended to cure HIV infection. The company's vaccine is based o
Drug Discovery
Barcelona, Spain
5 As of 2024

Plymouth Meeting, PA
 

Wilmington, DE
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Aelix Therapeutics Competitors (32)

One of Aelix Therapeutics’s 32 competitors is Inovio Pharmaceuticals, a Corporation company based in Plymouth Meeting, PA.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Inovio Pharmaceuticals Corporation Plymouth Meeting, PA
Ayala Pharmaceuticals Corporation Wilmington, DE
Kite Pharma Formerly VC-backed Santa Monica, CA
Cognition Therapeutics Formerly VC-backed New York, NY
CaroGen Venture Capital-Backed Farmington, CT
You’re viewing 5 of 32 competitors. Get the full list »

Aelix Therapeutics Patents

Aelix Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260063627-A1 Method of treatment of hiv infection with vaccine Pending 20-Jul-2023
WO-2025017540-A1 Method of treatment of hiv infection with vaccine Inactive 20-Jul-2023
WO-2024084441-A1 Combination hiv vaccine Inactive 19-Oct-2022
AU-2020384323-A1 Dosage regimens for vaccines Pending 14-Nov-2019
CA-3161633-A1 Dosage regimens for vaccines Pending 14-Nov-2019 A61K39/12
To view Aelix Therapeutics’s complete patent history, request access »

Aelix Therapeutics Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Aelix Therapeutics FAQs

  • When was Aelix Therapeutics founded?

    Aelix Therapeutics was founded in 2015.

  • Where is Aelix Therapeutics headquartered?

    Aelix Therapeutics is headquartered in Barcelona, Spain.

  • What is the size of Aelix Therapeutics?

    Aelix Therapeutics has 5 total employees.

  • What industry is Aelix Therapeutics in?

    Aelix Therapeutics’s primary industry is Drug Discovery.

  • Is Aelix Therapeutics a private or public company?

    Aelix Therapeutics is a Private company.

  • What is Aelix Therapeutics’s current revenue?

    The current revenue for Aelix Therapeutics is .

  • How much funding has Aelix Therapeutics raised over time?

    Aelix Therapeutics has raised $13.2M.

  • Who are Aelix Therapeutics’s competitors?

    Inovio Pharmaceuticals, Ayala Pharmaceuticals, Kite Pharma, Cognition Therapeutics, and CaroGen are some of the 32 competitors of Aelix Therapeutics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process